Institut Curie;UNIVERSITE DE MONTPELLIER;Centre National de la Recherche Scientifique (C.N.R.S.)
发明人:
TAZI, Jamal,GRIERSON, David,MAHUTEAU-BETZER, Florence,ROUX, Pierre
申请号：
DK09700499
公开号：
DK2235000T3
申请日:
2009.01.12
申请国别(地区):
DK
年份:
2020
代理人:
摘要：
The present invention relates to specific compounds； pharmaceutical composition comprising at least one of said compounds； and the use of at least one of said compounds in preparing a drug to treat, in a subject, a genetic disease resulting from at least one splicing anomaly.
